Story · Medicine & Biotech

FDA approves allogeneic regulatory T cell-based immunotherapy with HSPC and T cells-vldq for use in matched donor hematopoietic stem cell transplantation for adults with hematologic malignancies

1 outlet · first reported by FDA Drug Safety / Drugs feed 5d ago

Coverage, in order

  1. 5d ago
    FDA Drug Safety / Drugs feed indie
    FDA approves allogeneic regulatory T cell-based immunotherapy with HSPC and T cells-vldq for use in matched donor hematopoietic stem cell transplantation for adults with hematologic malignancies

    FDA approves allogeneic regulatory T cell-based immunotherapy with HSPC and T cells-vldq for use in matched donor hematopoietic stem cell transplantation for adults with hematologic malignancies

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.